The Scientist

» clinical trials and immunology

Most Recent

image: Clinical Silence

Clinical Silence

By | October 10, 2013

A study has shown that less than half of the outcomes of some clinical trials are publicly available.

0 Comments

image: Progress for First Malaria Vaccine

Progress for First Malaria Vaccine

By | October 8, 2013

Following successful clinical trials, GlaxoSmithKline says it will submit its malaria vaccine for European regulatory approval.

0 Comments

image: Criminal Hype

Criminal Hype

By | September 25, 2013

Overstating the benefits of a drug lands a former biotech executive in home detention.

0 Comments

image: Opinion: How HIV Became Positive

Opinion: How HIV Became Positive

By | September 17, 2013

Immunotherapies, such as the re-engineered T cells that last year saved a 7-year-old girl’s life, continue to show promise as cancer treatments.

1 Comment

image: Opinion: Translational Research in Crisis

Opinion: Translational Research in Crisis

By | September 10, 2013

Turning discoveries made in academic labs into innovative therapies requires a radically new approach.

2 Comments

image: Ovarian Cancer Screen Shows Promise

Ovarian Cancer Screen Shows Promise

By | August 27, 2013

A blood test for the protein CA-125, coupled with a vaginal ultrasound, can help detect the difficult-to-spot cancer.

0 Comments

image: Preliminary Malaria Vaccine Trial a Success

Preliminary Malaria Vaccine Trial a Success

By | August 9, 2013

An intravenous vaccine appears to protect adults from malaria infection in a Phase 1 clinical trial.

0 Comments

image: Pharma Moves Toward Transparency

Pharma Moves Toward Transparency

By | July 29, 2013

The pharmaceutical industry has agreed to share data from clinical trials with researchers, patients, and the public.

0 Comments

image: First Ever iPS-Cell Trial a Go

First Ever iPS-Cell Trial a Go

By | July 22, 2013

The Japanese government will allow a study of stem cell therapy using patients’ own cells, reprogrammed to be stem cells, to treat vision loss.

1 Comment

image: Week in Review, July 15–19

Week in Review, July 15–19

By | July 19, 2013

Bias in preclinical research; medical marijuana for kids; a swath of microbial genomes; plastic ocean habitats; rethinking scientific evaluation

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech